These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Initiation, progression and remission of diabetic nephropathy. Hovind P Dan Med Bull; 2005 Dec; 52(4):119-42. PubMed ID: 16764047 [No Abstract] [Full Text] [Related]
27. Improving microvascular outcomes in patients with diabetes through management of hypertension. McGill JB Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966 [TBL] [Abstract][Full Text] [Related]
28. [Albuminuria in the diabetic patient: practical management]. Kistler AD Praxis (Bern 1994); 2013 Oct; 102(20):1229-35. PubMed ID: 24088233 [TBL] [Abstract][Full Text] [Related]
29. [Nephroprotection: how to slow the progression of chronic renal insufficiency?]. Hannedouche T; Krummel T; Parvez-Braun L Nephrol Ther; 2005 May; 1(2):135-44. PubMed ID: 16895678 [TBL] [Abstract][Full Text] [Related]
30. Albuminuric and non-albuminuric pathways to renal impairment in diabetes. Macisaac RJ; Jerums G Minerva Endocrinol; 2005 Sep; 30(3):161-77. PubMed ID: 16208306 [TBL] [Abstract][Full Text] [Related]
32. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention. Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923 [No Abstract] [Full Text] [Related]
33. Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes. Earle KA; Harry D; Zitouni K Diabetes Res Clin Pract; 2008 Jan; 79(1):68-73. PubMed ID: 17766000 [TBL] [Abstract][Full Text] [Related]
34. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Bakris GL Mayo Clin Proc; 2011 May; 86(5):444-56. PubMed ID: 21531886 [TBL] [Abstract][Full Text] [Related]
36. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828 [TBL] [Abstract][Full Text] [Related]
37. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus. Agha A; Bashir K; Anwar E Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953 [TBL] [Abstract][Full Text] [Related]
39. Type 2 diabetes mellitus: prevention of macrovascular complications. Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994 [TBL] [Abstract][Full Text] [Related]
40. The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements. Rydén L; Waeber B; Ruilope LM; Mancia G; Volpe M; Holzgreve H; Mogensen CE; Laurent S Blood Press; 2008; 17(5-6):250-9. PubMed ID: 19012063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]